EMA Recommends Granting a Marketing Authorisation for Nirogacestat By Ogkologos - July 3, 2025 219 0 Facebook Twitter Google+ Pinterest WhatsApp It is intended for the treatment of adult patients with progressing desmoid tumours Source RELATED ARTICLESMORE FROM AUTHOR Advanced and metastatic prostate cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up PAXG Significantly Improves EFS Compared with mFOLFIRINOX in Patients with Resectable or Borderline Resectable Pancreatic Ductal Adenocarcinoma EMA Recommends Extension of Therapeutic Indications for Retifanlimab MOST POPULAR Cancer Patient’s Appetite Increases And His Blood Pressure Lowers After A... September 24, 2019 Using a Mind-Body Connection to Help You Cope During Cancer: An... January 11, 2024 Mom with Breast Cancer Who Had A Year to Live Goes... April 2, 2019 10 Tips for Healthy Eating After Cancer Treatment December 7, 2020 Load more HOT NEWS How Anxiety Impacts People With Cancer and How to Cope Self Destruction Why we need to continue to advocate for global tobacco control 24-Year-Old Diagnosed With Breast Cancer After Doctors Said Her Chest Was...
